Startup founder Charlie Javice found guilty of defrauding JPMorgan Chase in $175 million deal

3 weeks ago

In this article

Charlie Javice, who is charged with defrauding JPMorgan Chase & Co into buying her now-shuttered college financial aid startup Frank for $175 million in 2021, arrives at United States Court in Manhattan in New York City, June 6, 2023.

Mike Segar | Reuters

Charlie Javice, founder of a startup purchased by JPMorgan Chase in 2021, was convicted in federal court Friday of defrauding the bank by vastly overstating the company's customer list.

A spokesperson for JPMorgan declined to comment.

This story is developing. Please check back for updates.

Read Full Article at Source

Startup founder Charlie Javice found guilty of defrauding JPMorgan Chase in $175 million deal

Related

Canadian small businesses are taking Trump's tariffs personally

Netflix maintained its 2025 guidance. That may not be the sign of confidence it seems

American Express’ wealthy cardholders are mostly untouched by tariff jitters

Target CEO Cornell meets with Sharpton to discuss DEI rollback as civil rights leader considers boycott

Chinese tea chain Chagee climbs 15% in stock market debut

Netflix posts major earnings beat as revenue grows 13% in first quarter

Netflix earnings are out — here are the numbers

Chinese tea chain Chagee climbs 20% in stock market debut

American Express’s wealthy cardholders are mostly untouched by tariff jitters

American Express’s wealthy cardholders are mostly untouched by tariff jitters, CFO says

Chinese tea chain Chagee soars 30% in stock market debut

Chinese tea chain Chagee soars 40% in stock market debut

Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares jump 14%

UnitedHealth's stock is plunging on higher medical costs. That may mean trouble for more insurers

Target CEO Cornell to meet with Sharpton to discuss DEI rollback as civil rights leader considers boycott

Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients

Nissan aims to 'max out' U.S. production plant amid Trump's tariffs

Wall Street trading desks are feasting on the volatility from Trump’s global upheaval